publications-2007-2010

Peptide mass-assisted antibody cloning strategy for accurate characterization of potential therapeutic monoclonal antibodies against neurodegenerative diseases

Published on 19 March 2015

Peptide mass-assisted antibody cloning strategy for accurate characterization of potential therapeutic monoclonal antibodies against neurodegenerative diseases
Authors	Essono S, Clément G, Padiolleau-Lefevre S, Créminon C, Grassi J, Boquet D
Journal	PROTEIN ENGINEERING DESIGN & SELECTION 23 (4), 203-210, 2010
Year	2010
Institute	iBiTec-S

Retour à la liste

Top page

Alternative and Atomic Energies Agency

CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.

The Knowledge Factory

In the same section :

Peptide mass-assisted antibody cloning strategy for accurate characterization of potential therapeutic monoclonal antibodies against neurodegenerative diseases

Browse the site

Alternative and Atomic Energies Agency

Browse the portal

The Knowledge Factory

About Fundamental Research Division

Research fields

Scientific results

In the same section :

Peptide mass-assisted antibody cloning strategy for accurate characterization of potential therapeutic monoclonal antibodies against neurodegenerative diseases

Browse the site

Alternative and Atomic Energies Agency

Browse the portal